Bausch Health Companies Inc (BHC)

30.78
+0.01(+0.03%)
After Hours
30.80
+0.02(+0.06%)
- Real-time Data
  • Volume:
    1,536,931
  • Bid/Ask:
    30.80/31.60
  • Day's Range:
    30.53 - 31.09

BHC Overview

Prev. Close
30.77
Day's Range
30.53 - 31.09
Revenue
8.03B
Open
30.92
52 wk Range
14.86 - 34.8
EPS
-1.58
Volume
1,536,931
Market Cap
10.95B
Dividend (Yield)
N/A (N/A)
Average Vol. (3m)
4,974,400
P/E Ratio
N/A
Beta
1.73
1-Year Change
70.91%
Shares Outstanding
355,661,440
Next Earnings Date
May 11, 2021
What is your sentiment on Bausch Health Companies Inc?
or
Market is currently closed. Voting is open during market hours.

Bausch Health Companies Inc News

Bausch Health Companies Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellSellBuy
Technical IndicatorsStrong BuyBuyStrong SellStrong SellStrong Buy
SummaryStrong BuyNeutralStrong SellStrong SellStrong Buy

Bausch Health Companies Inc Company Profile

Bausch Health Companies Inc Company Profile

Employees
21600

Bausch Health Companies Inc, formerly Valeant Pharmaceuticals International Inc, is a Canada-based company that develops, manufactures and markets a range of branded and generic pharmaceuticals, medical devices and over-the-counter products. It primarily develops products in the therapeutic areas of eye health, gastroenterology and dermatology. Its dermatology products treat a range of conditions, including actinic keratosis, acne, atopic dermatitis, psoriasis and other dermatoses. It also offers a selection of aesthetic medical devices that address a variety of conditions, including facial wrinkles, acne, pigmentation conditions and laser hair removal, among others. The gastrointestinal (GI) segment offers products that treat GI and hepatologic conditions, including hepatic encephalopathy, irritable bowel syndrome with diarrhea and ulcerative colitis, among others. Its eye health products are marketed in the following categories: Contact Lens, Pharmaceutical Products and Surgical.

Read More
  • March 16, 2021 7:03am HC Wainwright & Co. Maintains Buy on Bausch Health Companies, Raises Price Target to $55
    0
    • Wonder in B+L spin off...will bausch health company be it's parent company holding 51% of it shares? Then should give bonus
      0
      • Teva has been dropping even though it posted result that beat analyst...so BHC??? Sell on news??
        0
        • monster going to awake
          0
          • Has to wait till 24 Feb?? CEO already said there will be profit from BHC all sector...but how come prices never go up and up?? Will it be giving bonus if bhc were to IPO listing L+B ?
            0
            • Wait until wallstreetbets get a hold of BHC.
              0
              • +9.93% Today
                0
                • Up up up
                  1
                  • Flirting with insolvency? How will it raise additional funds to cover its liabilities over the next 12 months? Long term debt issuance, asset sales in a global downturn, or diluting shareholder value? Not great choices really. Still, ratings agencies have a "stable" outlook on their current ratings for the Company.
                    0
                    • I think there should be Bausch Health day.
                      1
                      • Look like a junk stock...market down or rise, it also drop... terrible stock
                        1
                        • BHC Bausch Health Companies Holdings L.P. Valueact Director Buy 948,353 shares @ $19.24 $18,246,311.72 6/5/2020 $19.60
                          0
                          • Fake news...the CEO papa since last 2 years has always been buying at higher price...but stock still dropping 🤔
                            1
                        • There will be little correction on these share but I think its good share, it will nt go below 15
                          0
                          • IT will not go be sure it will go soon up to 20.14usd ? trust me . H.M. King Constantine II of Greece.
                            0
                        • should we buy at these rate 18.39 , or change my mood to another segment ,pls guide me
                          0
                          • I work at this company. It is currently trading at fair value...at best. They would love to be bought out, but need to get the debt down before any chance of that. At best, will be dead, stagnate moneynfor a solid decade. leadership below Papa is terribly weak. Good people. ,but very weak. They lack vision, innovation and creativity.
                            1
                            • Ben Strohguy is a desperate short
                              0
                            • Yeeeaaahhh, okaaaay.
                              0
                            • I don't work for this company but I know it will go to $25 in the next couple of weeks.
                              0
                          • being bought? this is pretty unreal run
                            0
                            • being bought? this is pretty unreal run
                              0
                              • The way this stock trades is criminal
                                0
                                • anyone know when the co is supposed to report earning? I thought its today.
                                  0
                                  • May 6
                                    0
                                • I tin cros are swinging the prices up and down to collect more pieces.
                                  0
                                  • anyone know when the co is supposed to report earning? I thought its today.
                                    0
                                • looks great. . ATR looks.  great
                                  0
                                  • $17.10 Breakout with very heavy volume on Friday. Volume Double than Average . Bullish
                                    0
                                    • Time to sell?
                                      0
                                      • no, time to buy and bulk!
                                        0
                                    • Fahmi Quadir nailed it!
                                      0
                                      • Now next level to watch 15.47
                                        2
                                        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.